Treatment of generalized anxiety disorder: Comparison of a new beta-blocking drug (CGP361A), low-dose neuroleptic (flupenthixol), and placebo. - Bjerrum,H.; Allerup,P.; Thunedborg,K.; Jakobsen,K.; Bech,P. (Pharmacopsychiatry, 1992)